Skip to page content
Office of Federal Contract Compliance Programs
Bookmark and Share

June 2011 Events and News

Women to Receive Compensation, Job Offers, After Investigation Reveals Discrimination

ThyssenKrupp Elevator Manufacturing Inc. has agreed to pay $288,333 to 248 women who were systematically rejected for positions at the company’s facility in Middleton, Tenn. The company also has agreed to make job offers to women from this group as positions become available. This follows an investigation by OFCCP into the company’s hiring practices for assembler/packer and utility positions.

“A company like ThyssenKrupp should know better than to underestimate the power of America's working women,” said OFCCP Director Patricia A. Shiu. “When the doors of opportunity are fully open to us, there isn’t a job that we can’t do.”

Read the Labor Department’s ThyssenKrupp Elevator Manufacturing Inc. news release about this case.


OFCCP Settles Equal Pay Case with Pharmaceutical Giant AstraZeneca

124 women will recover $250,000 following a pay discrimination lawsuit filed by the DOL against AstraZeneca, a provider of pharmaceutical products to hospitals around the country. The action follows an investigation conducted by OFCCP and resolves allegations that female sales specialists at the corporation’s Wayne, Pa facility were unfairly paid, on average, $1,700 less than their male counterparts for equal work. Under a consent decree and order filed with the department’s Office of Administrative Law Judges, in addition to making financial restitution, AstraZeneca has agreed to conduct statistical analysis of the base pay of 415 sales specialists and adjust salaries accordingly where females continue to be underpaid.

“I am glad AstraZeneca finally has agreed to pay its employees what they’ve earned,” said OFCCP Director Patricia A. Shiu, a member of President Obama’s National Equal Pay Enforcement Task Force. “More importantly, we look forward to working with the company’s management to make sure this does not happen again to anyone who works for AstraZeneca.”

If AstraZeneca fails to comply with the consent decree, it may be subject to sanctions, including cancellation of its current federal contract, valued at more than $2 billion, and debarment from acquiring future ones.

Read the Labor Department’s AstraZeneca news release for more information about this case.


VEVRAA NPRM Comment Period Extended

On April 26, 2011, the Office of Federal Contract Compliance Programs (OFCCP) published in the Federal Register a notice of proposed rulemaking (NPRM). This NPRM (76 FR 23358) proposes revising regulations implementing the affirmative action provisions of the Vietnam Era Veterans’ Readjustment Assistance Act of 1974, as amended.

The original comment period is scheduled to end on Monday, June 27, 2011. After receiving several requests for extensions, OFCCP is extending the comment period for this NPRM for 14 days until Monday, July 11, 2011. This action will provide all interested persons additional time to analyze the issues and provide their comments on the NPRM. Parties interested in commenting can view the NPRM and submit comments by using the Federal eRulemaking Portal and referencing RIN 1250–AA00.

OFCCP is publishing a Federal Register notice announcing this two–week extension of the comment period.